Ovarian cancer

• Health & Medicine

Pill and pregnancy have biggest effects on ovarian cancer risk

Taking the Pill for 10 years can reduce the risk of ovarian cancer by almost half (45 per cent), new research part-funded by Cancer Research UK shows today. Taking the Pill for 10 years can reduce the risk of ovarian cancer by almost half (45 per cent), new research part-funded by Cancer Research UK shows today.

26 October 2011

• Science & Technology
• Health & Medicine

Podcast: Bacteria, bowel cancer, sunscreen and smoking

20 September 2011

• Health & Medicine

Blocking key proteins could improve response to common chemotherapy drug

SCIENTISTS have discovered how blocking key cell signalling proteins could help boost the success rate of the tumour-shrinking drug paclitaxel, according to a study published in the journal Cancer Research. SCIENTISTS have discovered how blocking key cell signalling proteins could help boost the success rate of the tumour-shrinking drug paclitaxel, according to a study published in the journal Cancer Research.

1 September 2011

• Health & Medicine

Researchers trial new drug for women with hereditary breast and ovarian cancer

A Cancer Research UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford. A Cancer Research UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford.

17 August 2011

• Science & Technology

New ovarian cancer gene is a significant step forward

7 August 2011

• Science & Technology

Landmark ovarian cancer discovery as scientists unveil high risk gene

Cancer Research UK-funded scientists have discovered that women who carry a faulty copy of a gene called RAD51D have almost a one in 11 chance of developing ovarian cancer, the most significant ovarian cancer gene discovery for more than a decade, reveals a study in Nature Genetics today. Cancer Research UK-funded scientists have discovered that women who carry a faulty copy of a gene called RAD51D have almost a one in 11 chance of developing ovarian cancer, the most significant ovarian cancer gene discovery for more than a decade, reveals a study in Nature Genetics today.

7 August 2011

• Science & Technology
• Health & Medicine

Widening the net for PARP inhibitors

12 July 2011

• Science & Technology
• Health & Medicine

ASCO 2011 – Jury still out on ovarian cancer screening

30 June 2011

• Health & Medicine

Gene fault could predict ovarian cancer drug success

Faults in a gene commonly inactivated in many different types of cancer could be used to predict which drug combination ovarian cancer patients are most likely to benefit from, according to results presented at the American Society for Clinical Oncology today. Faults in a gene commonly inactivated in many different types of cancer could be used to predict which drug combination ovarian cancer patients are most likely to benefit from, according to results presented at the American Society for Clinical Oncology today.

6 June 2011

• Health & Medicine

Podcast: Screening, radiotherapy, and Seve Ballasteros

18 May 2011

• Science & Technology
• Health & Medicine

Ovarian cancer treatment – a bright future

14 March 2011